The changing face of AA amyloidosis

Amyloid and Amyloidosis

Volumn , Issue , 2004, Pages 517-520

  Hazenberg, B P C ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84974794614     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (29)

1. Simms RW, Prout MN, Cohen AS. The epidemiology of AL and AA amyloidosis. In: Husby G, editor. Reactive amyloidosis and the acute phase response. Bailliere’s Clinical Rheumatology. London: Bailliere Tindall, 1994:627-34
2. Baum J, Gutowska G. Death in juvenile rheumatoid arthritis. Arthritis Rheum 1977; 20 (Supp l):253-5
3. Filipowics-Sosnowska AM, Rostropowicz-Denisiewics K, Rosenthal CJ, Baum J. The amyloidosis of juvenile rheumatoid arthritis. Compararive studies in Polish and American children. Arthritis Rheum 1978; 21: 699-703
4. Missen GA, Taylor JD. Amyloidosis in rheumatoid arthritis. J Pathol 1956; 71:179-84
5. Bland JH. Clinical incidence of renal amyloidosis in rheumatoid arthritis. J Maine Med Assoc 1965; 56:251-5
6. Laiho K, Tiitinen S, Kaarela K, Helin H, Isomäki H. Secondary amyloidosis has decreased in patients with inflammatory joint diseases in Finland. Clin Rheum 1999;18:122-3
7. Myllykangas-Luosujärvi R, Aho K, Kautiainen H, Hakala M. Amyloidosis in a nationwide series of 1666 subjects with rheumatoid arthritis who died during 1989 in Finland. Rheumatology 1999;38:499-503
8. Cooke RA, Champness LT. Amyloidosis in Papua-New Guinea. Med J Aust 1970; 2:1177-84
9. James PD, Owor R. Systemic amyloidosis in Uganda: an autopsy study. Trans R Soc Trop Med Hyg 1975; 69:480-3
10. Chugh KS, Datta BN, Singhal PC, et al. Pattern of renal amyloidosis in Indian patients. Postgrad Med J 1981; 57:31-5
11. Mody G, Bowen R, Meyers OL. Amyloidosis at Groote Schuur Hospital, Cape Town. S Afr Med J 1984; 66:47-9
12. Dahlin DC. Secondary amyloidosis. Ann Intern Med 1949; 31:105-19
13. Kuhlbäck B, Wegelius O. Secondary amyloidosis: a study of clinical and pathological findings. Acta Med Scand 1966; 180:737-45
14. Brownstein MH, Helwig EB. Secondary systemic amyloidosis: analysis of underlying disorders. South Med J 1971; 64:491-6
15. Boussema E, Labeeuw M, Colon S, Caillette A, Zech P. Maladies associées à l’amylose rénale: À propos de 216 cas. Ann Med Interne 1991; 142:331-4
16. Hoshii Y, Takahashi M, Ishihara T, Uchino M. Immunohistochemical classification of 140 autopsy cases with systemic amyloidosis. Pathol Int 1994; 44:352-8
17. Brandt K, Cathcart ES, Cohen AS. A clinical analysis of the course and prognosis of forty-two patients with amyloidosis. Am J Med 1968; 44:955-69
18. Gertz MA, Kyle RA. Secondary systemic amyloidosis: response and survival in 64 patients. Medicine 1991; 70:246-56
19. Browning MJ, Banks RA, Tribe CR, et al. Ten years' experience of an amyloid clinic-a clinicopathological survey. Q J Med 1985; 54:213-27
20. Janssen S, Van Rijswijk MH, Meijer S, et al. Systemic amyloidosis: a clinical survey of 144 cases. Neth J Med 1986; 29:376-85
21. Hazenberg BP, Van Rijswijk MH. Aspects cliniques de l’amylose AA. In: Grateau G, Benson MD, Delpech M, editors. Les Amyloses. Paris: Flammarion, 2000:377-427
22. Joss N, McLaughlin K, Simpson K, Boulton-Jones JM. Presentation, survival and prognostic markers in AA amyloidosis. Q J Med 2000; 93:535-42
23. Chevrel G, Jenvrin C, McGregor B, Miossec P. Renal type AA amyloidosis associated with rheumatoid arthritis: a cohort study showing improved survival on treatment with pulse cyclophosphamide. Rheumatology 2001; 40:821-5
24. Knutar O, Pettersson T, Tornroth T, Maury CPJ. AA amyloidosis without definable underlying disease. In: Bely M, Apathy A, editors. Amyloid and Amyloidosis. Hungary, 2001:168-70
25. Garceau D, Briand R, Hughes L, Gurbindo C, et al. A prospective analysis of demography, etiology, and clinical findings of AA amyloidosis patients enrolled in the international clinical Phase II/III Fibrillex study. Presented at Xth International Symposium on Amyloid and Amyloidosis, Tours, April 18-22, 2004: O18
26. Lachmann HJ, Goodman HJB, Gallimore J, et al. Characteristics and clinical outcome of 340 patients with systemic AA amyloidosis. Presented at Xth International Symposium on Amyloid and Amyloidosis, Tours, April 18-22, 2004: O16
27. El Mansoury TM, Hazenberg BP, El Badawy SA, et al. Screening for amyloid in subcutaneous fat tissue of Egyptian patients with rheumatoid arthritis: clinical and laboratory characteristics. Ann Rheum Dis 2002;61:42-7
28. Gomez-Casanovas E, Sanmarti R, Sole M, Canete JD, Munoz-Gomez J. The clinical significance of amyloid fat deposits in rheumatoid arthritis: a systematic long-term follow-up study using abdominal fat aspiration. Arthritis Rheum 2001; 44:66-72
29. Wakhlu A, Krisnani N, Hissaria P, Aggarwal A, Misra R. Prevalence of secondary amyloidosis in Asian North Indian patients with rheumatoid arthritis. J Rheumatol 2003; 30:948-51